Gene:
Gene Symbol:
TATDN2
Gene Name:
TatD DNase domain containing 2
Original Clone ID:
U2495CJ100-174_nHalo
Keyword:
None
Species:
Homo sapiens
Type:
cDNA
Vector Name:
pDONR221
Format:
FUSION
Source:
Center for Personalized Diagnostics
Description:
None
Comments:
None
Mutation / Discrepancy:
No / No
Publications:
None
Authors:
Center for Personalized Diagnostics
HsCD00945148
Price:
Login for Pricing
AVAILABLE
No restriction
Special MTA: None
Special MTA: None
Insert sequence: 2286nts
Open reading frame: 1 to 2286
ATGGCGTCCGAGCGGGGCAAGGTCAAGCACAACTGGAGCAGCACGTCGGAAGGGTGTCCC
CGCAAGCGCAGCTGCCTCCGGGAGCCCTGTGATGTGGCCCCCTCCAGCCGGCCAGCTCAG
AGGTCTGCGTCGCGTTCTGGAGGGCCCAGCAGCCCCAAGCGCCTGAAAGCCCAGAAGGAG
GACGATGTGGCTTGCTCGCGGAGGTTATCCTGGGGCTCATCCCGCCGCAGAAATAACTCC
TCCTCCTCCTTCTCCCCACATTTCTTGGGCCCTGGTGTGGGCGGGGCCGCCTCCAAAGGC
TGCCTGATTCGGAACACTCGGGGGTTCCTGTCTTCAGGGGGATCCCCTCTGCGTCCTGCC
AACGCCTCTTTGGAAGAAATGGCTTCTCTAGAGGAGGAAGCCTGCAGCCTTAAGGTTGAT
TCCAAAGATAGTTCTCATAACTCCACAAACTCTGAATTTGCAGCTGAAGCTGAGGGTCAG
AATGATACAATTGAGGAACCCAACAAGGTCCAGAAAAGGAAGAGGGATAGACTTCGAGAC
CAGGGCTCCACAATGATCTACCTGAAGGCTATCCAGGGCATCCTGGGGAAATCGATGCCA
AAAAGGAAGGGAGAGGCTGCCACTCGGGCAAAACCAAGCGCAGCAGAGCATCCCAGCCAT
GGAGAAGGACCAGCCAGGAGTGAAGGACCAGCCAAGACTGCAGAAGGAGCAGCCAGGAGT
GTCACAGTCACTGCTGCTCAGAAGGAGAAAGACGCAACCCCAGAGGTCAGCATGGAGGAG
GATAAGACAGTGCCAGAGAGGAGCAGCTTCTATGACAGGAGAGTAGTTATAGACCCTCAA
GAGAAACCCAGTGAGGAGCCCCTTGGGGACCGAAGGACTGTCATTGACAAATGCTCTCCA
CCCCTAGAGTTCTTGGATGACTCTGACTCTCATTTAGAAATCCAAAAGCATAAAGATAGG
GAGGTGGTGATGGAGCACCCCTCTTCTGGAAGTGACTGGTCTGATGTTGAGGAGATCTCC
ACAGTCAGATTCTCTCAGGAGGAACCTGTCTCCCTGAAACCTTCAGCCGTTCCGGAGCCT
TCTTCCTTCACCACCGACTATGTCATGTACCCTCCTCATTTGTACAGTAGTCCTTGGTGT
GACTACGCCAGCTATTGGACCAGCAGCCCCAAGCCTTCTAGCTACCCCTCCACAGGCAGC
AGCAGCAACGATGCAGCCCAGGTTGGGAAGAGCAGCCGGAGCCGCATGAGTGATTATTCC
CCCAACTCTACAGGGAGTGTCCAAAACACCTCCAGAGACATGGAGGCCTCAGAGGAAGGC
TGGTCCCAGAATTCTCGTTCATTTCGCTTCTCCAGAAGCTCAGAAGAAAGAGAGGTGAAG
GAGAAAAGAACATTCCAAGAGGAGATGCCTCCGCGTCCTTGTGGAGGACACGCATCCAGC
TCCCTGCCAAAGAGCCACCTGGAGCCAAGCCTAGAGGAGGGCTTCATTGACACTCATTGT
CACCTGGACATGCTCTATTCCAAGCTATCTTTCCAAGGGACCTTTACAAAGTTCAGAAAA
ATTTACAGCAGCTCCTTCCCTAAGGAATTTCAGGGCTGCATCTCTGACTTCTGTGATCCC
CGCACCCTGACAGATTGCCTATGGGAGGAGCTGTTGAAAGAGGATCTGGTCTGGGGGGCC
TTTGGCTGTCACCCTCATTTTGCACGTTACTACAGTGAGAGTCAAGAAAGAAATCTTTTG
CAAGCCTTAAGGCACCCTAAGGCTGTGGCATTTGGAGAAATGGGCTTGGATTACTCTTAC
AAGTGCACCACGCCTGTCCCAGAACAGCACAAGGTATTTGAGAGACAGCTGCAGCTGGCT
GTGTCTCTAAAGAAGCCCTTGGTGATCCACTGCCGAGAAGCTGATGAAGATCTGCTAGAA
ATCATGAAAAAGTTTGTGCCCCCTGACTACAAGATCCATAGGCATTGCTTCACCGGCAGC
TACCCGGTCATTGAGCCCCTGCTGAAGTACTTTCCCAACATGTCTGTGGGCTTCACGGCA
GTGCTGACATACTCCTCTGCCTGGGAGGCCCGGGAAGCCTTGAGGCAGATCCCACTGGAG
AGAATCATCGTGGAAACGGATGCTCCCTATTTCCTCCCTCGCCAGGTTCCCAAAAGCCTT
TGCCAGTATGCCCACCCGGGCCTGGCCTTGCATACGGTCCGAGAGATTGCCAGAGTCAAA
GATCAGCCACTCTCCCTCACCTTGGCTGCCTTGCGTGAGAACACCAGTCGCCTCTACAGT
CTTTTG
Protein sequence predicted based on nucleotide sequence
MASERGKVKHNWSSTSEGCPRKRSCLREPCDVAPSSRPAQRSASRSGGPSSPKRLKAQKE DDVACSRRLSWGSSRRRNNSSSSFSPHFLGPGVGGAASKGCLIRNTRGFLSSGGSPLRPA NASLEEMASLEEEACSLKVDSKDSSHNSTNSEFAAEAEGQNDTIEEPNKVQKRKRDRLRD QGSTMIYLKAIQGILGKSMPKRKGEAATRAKPSAAEHPSHGEGPARSEGPAKTAEGAARS VTVTAAQKEKDATPEVSMEEDKTVPERSSFYDRRVVIDPQEKPSEEPLGDRRTVIDKCSP PLEFLDDSDSHLEIQKHKDREVVMEHPSSGSDWSDVEEISTVRFSQEEPVSLKPSAVPEP SSFTTDYVMYPPHLYSSPWCDYASYWTSSPKPSSYPSTGSSSNDAAQVGKSSRSRMSDYS PNSTGSVQNTSRDMEASEEGWSQNSRSFRFSRSSEEREVKEKRTFQEEMPPRPCGGHASS SLPKSHLEPSLEEGFIDTHCHLDMLYSKLSFQGTFTKFRKIYSSSFPKEFQGCISDFCDP RTLTDCLWEELLKEDLVWGAFGCHPHFARYYSESQERNLLQALRHPKAVAFGEMGLDYSY KCTTPVPEQHKVFERQLQLAVSLKKPLVIHCREADEDLLEIMKKFVPPDYKIHRHCFTGS YPVIEPLLKYFPNMSVGFTAVLTYSSAWEAREALRQIPLERIIVETDAPYFLPRQVPKSL CQYAHPGLALHTVREIARVKDQPLSLTLAALRENTSRLYSLL
Coding Sequence Details
Insert Sequence Verified?:
Y
Verification Method:
Sequence Verification
Mutations:
None
Discrepancy:
None
5' Linker Sequence:
None
3' Linker Sequence:
None
Recommended Growth Condition:
Distributed in bacterial strain:
DH5-alpha T1 phage resistant
Antibiotic Selection:
Host Type:
bacterial
Marker:
kanamycin
Bacterial Selection Condition:
50ug/mL kanamycin
Growth Condition:
Growth with the single antibiotic in LB at 37 degrees is recommended.
Comments:
Conditions for Gateway-type vectors in recombined (with insert) form and other kanamycin resistant vectors.
Protein Expression Results:
None
Recommended expression in:
Not Applicable
Vector Name:
pDONR221
Synonyms:
''
Description:
Gateway®, donor (entry), recombinational cloning clone, bacterial expression expression with rrnB T2 and rrnB T1 and M13 forward and attP1 and ccdB and CmR and cat_promoter-var002 and attP2 and T7 promoter and M13 reverse and KanR and ori; 50ug/mL of Kanamycin resistance in Pichia;
Comments:
The position of features were determined for the unrecombined (empty) form of the vector, which is described in detail on the Invitrogen website.
Size (bp):
4762
Parent Vector:
None
Properties:
Gateway, bacterial expression, donor (entry), recombinational cloning
Author Name:
Invitrogen
Publications:
None
Vector Map:
Vector Sequence:
Sequence:
Vector Features:
Type
Name
Description
Start
End
CDS
ccdB
CcdB, a bacterial toxin that poisons DNA gyrase
1197
1502
CDS
CmR
confers resistance to chloramphenicol
1847
2506
CDS
KanR
confers resistance to kanamycin in bacteria or G418 (Geneticin) in eukaryotes
3156
3965
Terminator
rrnB T2
transcription terminator T2 from the E. coli rrnB gene
268
295
Terminator
rrnB T1
transcription terminator T1 from the E. coli rrnB gene
387
473
primer_bind
M13 forward
common sequencing primer, one of multiple similar variants
537
553
primer_bind
M13 reverse
common sequencing primer, one of multiple similar variants
3027
3043
promoter
cat_promoter-var002
promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase
2507
2609
promoter
T7 promoter
promoter for bacteriophage T7 RNA polymerase
3004
3022
protein binding site
attP1
recombination site for the Gateway BP reaction
570
801
protein binding site
attP2
recombination site for the Gateway BP reaction
2754
2985
rep_origin
ori
high-copy-number ColE1/pMB1/pBR322/pUC origin of replication
4112
4700
